{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:00:26Z","timestamp":1780574426625,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.radonc.2024.110263","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T16:16:46Z","timestamp":1711729006000},"page":"110263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6744-6152","authenticated-orcid":false,"given":"Kjersti","family":"Skipar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0529-6077","authenticated-orcid":false,"given":"Tord","family":"Hompland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjersti V.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taran P.","family":"Hellebust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjersti","family":"Bruheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7938-0514","authenticated-orcid":false,"given":"Heidi","family":"Lyng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110263_b0005","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.radonc.2011.07.012","article-title":"Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer","volume":"100","author":"Potter","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0015","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2018.06.014","article-title":"Tumor shrinkage during chemoradiation in locally advanced Cervical cancer patients: prognostic significance, and impact for image-guided adaptive Brachytherapy","volume":"102","author":"Schernberg","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110263_b0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13014-015-0559-5","article-title":"Consecutive magnetic resonance imaging during brachytherapy for cervical carcinoma: predictive value of volume measurements with respect to persistent disease and prognosis","volume":"10","author":"Mongula","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0360-3016(01)01808-9","article-title":"Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging","volume":"52","author":"Mayr","year":"2002","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110263_b0035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2007.06.022","article-title":"The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI","volume":"107","author":"Nam","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113471","article-title":"Prognostic significance of tumor regression rate during concurrent chemoradiotherapy in locally advanced cervix cancer: analysis by radiation phase and histologic type","volume":"9","author":"Kang","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.radonc.2024.110263_b0045","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1002\/cncr.25260","article-title":"Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy","volume":"116","author":"Wang","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110263_b0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijrobp.2021.04.022","article-title":"Nomogram predicting overall survival in patients with locally advanced Cervical cancer treated with radiochemotherapy including image-guided Brachytherapy: a retro-EMBRACE study","volume":"111","author":"Sturdza","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110263_b0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-8140(98)00044-9","article-title":"Oxygenation predicts radiation response and survival in patients with cervix cancer","volume":"48","author":"Fyles","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0060","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0065","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2012.171","article-title":"Imaging hypoxia to improve radiotherapy outcome","volume":"9","author":"Horsman","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2007.06.033","article-title":"Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modeling and correlation with tumor hypoxia","volume":"70","author":"Lim","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110263_b0075","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00066-012-0260-7","article-title":"Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients","volume":"189","author":"Schmid","year":"2013","journal-title":"A low-field MRI study Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2024.110263_b0080","article-title":"Prognostic value of Mandard's tumor regression grade (TRG) in post chemo-radiotherapy Cervical cancer","volume":"13","author":"Scaglione","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.radonc.2024.110263_b0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s003840050072","article-title":"Pathological features of rectal cancer after preoperative radiochemotherapy","volume":"12","author":"Dworak","year":"1997","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.radonc.2024.110263_b0090","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/RCT.0b013e31819e93af","article-title":"Diffusion-weighted magnetic resonance imaging of uterine cervical cancer","volume":"33","author":"Liu","year":"2009","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.radonc.2024.110263_b0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijrobp.2022.02.005","article-title":"Prognostic implications of uterine Cervical cancer regression during chemoradiation evaluated by the T-score in the multicenter EMBRACE I study","volume":"113","author":"Lindegaard","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110263_b0100","article-title":"Evaluation of a new prognostic tumor score in locally advanced cervical cancer integrating clinical examination and magnetic resonance imaging","author":"Lindegaard","year":"2019","journal-title":"Int J of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110263_b0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.radonc.2022.09.002","article-title":"Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET\/CT in locally advanced cervical cancer","volume":"176","author":"Skipar","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0115","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-17-3806","article-title":"Combined MR imaging of oxygen consumption and supply reveals tumor hypoxia and aggressiveness in prostate cancer patients","volume":"78","author":"Hompland","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2024.110263_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102841","article-title":"Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity","volume":"57","author":"Fjeldbo","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.radonc.2024.110263_b0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2015.09.009","article-title":"Sorafenib increases tumor hypoxia in Cervical cancer patients treated with radiation therapy: results of a phase 1 clinical study","volume":"94","author":"Milosevic","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110263_b0130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijrobp.2009.04.084","article-title":"Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer","volume":"77","author":"Mayr","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110263_b0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phro.2019.03.001","article-title":"Cervical cancer apparent diffusion coefficient values during external beam radiotherapy","volume":"9","author":"de Boer","year":"2019","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0140","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.mri.2014.05.009","article-title":"Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging","volume":"32","author":"Park","year":"2014","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2024.110263_b0145","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/jog.12276","article-title":"Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer","volume":"40","author":"Makino","year":"2014","journal-title":"The Journal of Obstetrics and Gynaecology Research"},{"key":"10.1016\/j.radonc.2024.110263_b0150","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3389\/fonc.2020.00562","article-title":"Tumor hypoxia: impact on radiation therapy and Molecular pathways","volume":"10","author":"S\u00f8rensen","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0155","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2024.110263_b0160","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1200\/JCO.23.01308","article-title":"Hypoxia-directed treatment of human papillomavirus-related Oropharyngeal Carcinoma","volume":"42","author":"Lee","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/ijgc-2021-002492","article-title":"Advances in immunotherapy for cervical cancer: recent developments and future directions","volume":"32","author":"Sherer","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2024.110263_b0170","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ijgc-2022-003758","article-title":"Advances in immunotherapy in cervical cancer","volume":"33","author":"Grau","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2024.110263_b0175","doi-asserted-by":"crossref","first-page":"S1279","DOI":"10.1016\/j.annonc.2023.10.032","article-title":"LBA38 pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: a randomized, double-blind, phase III ENGOT-cx11\/GOG-3047\/KEYNOTE-A18 study","volume":"34","author":"Lorusso","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2024.110263_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100787","article-title":"Hypoxia as a driver of resistance to immunotherapy","volume":"59","author":"Kopecka","year":"2021","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.radonc.2024.110263_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.918528","article-title":"Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cells","volume":"13","author":"Mohan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2024.110263_b0190","article-title":"Improving cancer immunotherapy: exploring and Targeting metabolism in hypoxia microenvironment","volume":"13","author":"Wei","year":"2022","journal-title":"Front Immunol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024001853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024001853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T17:39:28Z","timestamp":1741455568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024001853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":38,"alternative-id":["S0167814024001853"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110263","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110263"}}